Literature DB >> 14988005

Neurofibromin is actively transported to the nucleus.

Ina Vandenbroucke1, Patrick Van Oostveldt, Elisabeth Coene, Anne De Paepe, Ludwine Messiaen.   

Abstract

Mutations in the neurofibromatosis type 1 (NF1) tumor suppressor gene predispose individuals to a variety of benign and malignant tumors. Many tumor suppressors 'shuttle' between the nucleus and the cytoplasm, thus regulating their function. By expressing different NF1 constructs in COS-7 cells (encompassing exons 28-49 and fused to the green fluorescent protein), we identified a functional nuclear localization signal (NLS) in exon 43. Mutation of the NLS completely abolishes the nuclear entry of the NF1-derivative fusion protein. A highly expressed splice variant that lacks this NLS controls the localization and hence the function of neurofibromin. The localization of neurofibromin in the nucleus may provide novel clues to unknown functions for NF1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14988005     DOI: 10.1016/S0014-5793(04)00078-X

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Authors:  Steven L Carroll
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

2.  Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.

Authors:  Jean L Nakamura; Connie Phong; Emile Pinarbasi; Scott C Kogan; Scott Vandenberg; Andrew E Horvai; Bruce A Faddegon; Dorothea Fiedler; Kevan Shokat; Benjamin T Houseman; Richard Chao; Russell O Pieper; Kevin Shannon
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

Review 3.  Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.

Authors:  Nicole M Brossier; Steven L Carroll
Journal:  Brain Res Bull       Date:  2011-08-10       Impact factor: 4.077

4.  Differential Regulation of RasGAPs in Cancer.

Authors:  Thomas Grewal; Meryem Koese; Francesc Tebar; Carlos Enrich
Journal:  Genes Cancer       Date:  2011-03

Review 5.  Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms.

Authors:  Marco Tartaglia; Bruce D Gelb
Journal:  Ann N Y Acad Sci       Date:  2010-10-19       Impact factor: 5.691

6.  Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase.

Authors:  Frederick Kweh; Min Zheng; Elena Kurenova; Margaret Wallace; Vita Golubovskaya; William G Cance
Journal:  Mol Carcinog       Date:  2009-11       Impact factor: 4.784

7.  Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.

Authors:  Ze-Yi Zheng; Meenakshi Anurag; Jonathan T Lei; Jin Cao; Purba Singh; Jianheng Peng; Hilda Kennedy; Nhu-Chau Nguyen; Yue Chen; Philip Lavere; Jing Li; Xin-Hui Du; Burcu Cakar; Wei Song; Beom-Jun Kim; Jiejun Shi; Sinem Seker; Doug W Chan; Guo-Qiang Zhao; Xi Chen; Kimberly C Banks; Richard B Lanman; Maryam Nemati Shafaee; Xiang H-F Zhang; Suhas Vasaikar; Bing Zhang; Susan G Hilsenbeck; Wei Li; Charles E Foulds; Matthew J Ellis; Eric C Chang
Journal:  Cancer Cell       Date:  2020-03-05       Impact factor: 31.743

8.  Individual Response to Radiation of Individuals with Neurofibromatosis Type I: Role of the ATM Protein and Influence of Statins and Bisphosphonates.

Authors:  Patrick Combemale; Laurène Sonzogni; Clément Devic; Zuzana Bencokova; Mélanie Lydia Ferlazzo; Adeline Granzotto; Steven Franck Burlet; Stéphane Pinson; Mona Amini-Adle; Joëlle Al-Choboq; Larry Bodgi; Michel Bourguignon; Jacques Balosso; Jean-Thomas Bachelet; Nicolas Foray
Journal:  Mol Neurobiol       Date:  2021-11-02       Impact factor: 5.590

Review 9.  Neurofibromin and suppression of tumorigenesis: beyond the GAP.

Authors:  Juan Mo; Stefanie L Moye; Renee M McKay; Lu Q Le
Journal:  Oncogene       Date:  2022-01-23       Impact factor: 8.756

10.  Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I.

Authors:  Min Xu; Hui Xiong; Yanfang Han; Chijun Li; Shaozhen Mai; Zhongzhou Huang; Xuechen Ai; Zhixuan Guo; Fanqin Zeng; Qing Guo
Journal:  Front Genet       Date:  2018-07-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.